(Q34340400)

English

The clinical and cost considerations of bisphosphonates in preventing bone complications in patients with metastatic breast cancer or multiple myeloma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

Europe PubMed Central

The clinical and cost considerations of bisphosphonates in preventing bone complications in patients with metastatic breast cancer or multiple myeloma (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

metastatic breast cancer

1 reference

based on heuristic

inferred from title

author name string

McCloskey EV

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Guest JF

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Kanis JA

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

61

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1253-1274

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Effects of clodronate on immobilization bone loss.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does myeloma secrete an osteoblast inhibiting factor?

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: a double-blind, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A single infusion of the bisphosphonate AHPrBP (APD) as treatment of Paget's disease of bone

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of glucocorticoids on the biologic activities of myeloma cells: inhibition of interleukin-1 beta osteoclast activating factor-induced bone resorption

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic impact of using clodronate in the management of patients with multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma. Finnish Leukaemia Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of early age at menopause on vertebral bone mass

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of clodronate on vertebral fracture risk in osteoporosis: a 1-year interim analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cellular regulatory mechanisms that may underlie the effects of corticosteroids on bone

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alendronate. A review of its pharmacological properties and therapeutic efficacy in postmenopausal osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clodronate kinetics and bioavailability

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Esophagitis associated with the use of alendronate

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clodronate therapy of metastatic bone disease in patients with prostatic carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective, controlled, nonrandomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple-myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stimulation of calcium reabsorption observed in advanced breast cancer patients with hypercalcemia and multiple bone metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone disease in multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral clodronate and reduction in loss of bone mineral density in women with operable primary breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal failure associated with intravenous diphosphonates

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant clodronate treatment does not reduce the frequency of skeletal metastases in node-positive breast cancer patients: 5-year results of a randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of skeletal disease in breast cancer: a controlled clodronate trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adverse effects of bisphosphonates. A comparative review

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-1 beta rather than lymphotoxin as the major bone resorbing activity in human multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of secretory products of breast cancer cells on osteoblast-like cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subgroup and cost-benefit analysis of the Finnish multicentre trial of clodronate in multiple myeloma. Finnish Leukaemia Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evolution of bone densitometry in patients with myeloma treated with conventional or intensive therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mineralisation defects with pamidronate therapy for Paget's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction in new metastases in breast cancer with adjuvant clodronate treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The assessment of vertebral deformity: a method for use in population studies and clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A high incidence of vertebral fracture in women with breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myeloma affects both the growth and function of human osteoblast-like cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative histology of myeloma-induced bone changes

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

British Association of Surgical Oncology Guidelines. The management of metastatic bone disease in the United Kingdom. The Breast Specialty Group of the British Association of Surgical Oncology

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Failure of oral pamidronate to reduce skeletal morbidity in multiple myeloma: a double-blind placebo-controlled trial. Danish-Swedish co-operative study group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of pamidronate in breast cancer with bone metastases: a randomized, double-blind placebo-controlled multicenter study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Femoral fractures in postmenopausal breast cancer patients treated with adjuvant tamoxifen

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clodronate decreases the frequency of skeletal metastases in women with breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rationale for the use of bisphosphonates in bone metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Side effects of disodium aminohydroxypropylidenediphosphonate (APD) during treatment of bone diseases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bisphosphonates: mechanisms of action

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of daily etidronate on the osteolysis of multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The acute-phase response after bisphosphonate administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring the action of clodronate with type I collagen metabolites in multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative effects of clodronate and calcitonin on bone in metastatic breast cancer: a histomorphometric study

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of first treatment with aminobisphosphonates pamidronate and ibandronate on circulating lymphocyte subpopulations

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term controlled trial with diphosphonate in patients with osteolytic bone metastases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pooling of clodronate urinary excretion data: a new pharmacokinetic method to study drugs with highly variable gastrointestinal absorption

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term oral pamidronate treatment inhibits osteoclastic bone resorption and bone turnover without affecting osteoblastic function in multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dichloromethylene-diphosphonate in patients with prostatic carcinoma metastatic to the skeleton

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind, placebo-controlled, dose-response trial of oral clodronate in patients with bone metastases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

APD in Paget's disease of bone. Role of the mononuclear phagocyte system?

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clodronate as a cause of aminotransferase elevation

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An evaluation of the potential cost reductions resulting from the use of clodronate in the treatment of metastatic carcinoma of the breast to bone

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of clodronate in patients with metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessing vertebral fractures. National Osteoporosis Foundation Working Group on Vertebral Fractures

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Timing of food intake has a marked effect on the bioavailability of clodronate

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of bone response to systemic therapy in an EORTC trial: preliminary experience with the use of collagen cross-link excretion. European Organization for Research and Treatment of Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of osteoporotic fractures in women with breast cancer: a population-based cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clodronate improves bone mineral density in post-menopausal breast cancer patients treated with adjuvant antioestrogens

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bisphosphonates in multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-Term Effects of Dichloromethylene Diphosphonate (Cl2 DP) on skeletal Lesions in Multiple Myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, controlled trial of intravenous clodronate in patients with metastatic bone disease and pain

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pamidronate in prevention of bone complications in metastatic breast cancer: a cost-effectiveness analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of glucocorticoids on osteoclast-activating factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diphosphonates for osteolytic metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

From polyphosphates to bisphosphonates and their role in bone and calcium metabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimal frequency of administration of pamidronate in patients with hypercalcaemia of malignancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral bisphosphonates: A review of clinical use in patients with bone metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of painful bone lesions and hypercalcemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Abnormal bone remodelling in patients with myelomatosis and normal biochemical indices of bone resorption

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secretory products of breast cancer cells specifically affect human osteoblastic cells: partial characterization of active factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced morbidity from skeletal metastases in breast cancer patients during long-term bisphosphonate (APD) treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationships between biochemical and symptomatic response in a double-blind randomised trial of pamidronate for metastatic bone disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/11511021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003495-200161090-00003

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34340400&oldid=2196524473"